Weight-loss drugs reduce kidney risk
This is a Glucagon news story, published by Guardian.
Glucagon news
For more Glucagon news, you can click here:
more Glucagon newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsGuardian news
For more news from Guardian, you can click here:
more news from GuardianAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
weight loss drugs. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest kidney outcomes news, receptor agonists news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Lancet DiabetesGuardian
•Weight-loss drugs can improve kidney health, study finds
83% Informative
Glucagon -like peptide-1 ( GLP-1 ) receptor agonists are a family of medications that help people shed the pounds, manage blood sugar in patients with type 2 diabetes and prevent heart attacks and strokes in people with heart disease.
Researchers conducted a meta-analysis of 11 large-scale clinical trials of weight loss drugs involving more than 85,000 people.
VR Score
88
Informative language
91
Neutral language
61
Article tone
formal
Language
English
Language complexity
60
Offensive language
likely offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
1
Source diversity
1
Affiliate links
no affiliate links